Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Will The Osteoarthritis Market Valuation Change Between Now And 2029?
Over recent years, the osteoarthritis market has seen significant growth. Anticipated to increase from $6.87 billion in 2024 to $7.49 billion in 2025, the market’s compound annual growth rate (CAGR) stands at 9.1%. The growth experienced during the historic period can be attributed to factors such as the aging population, the obesity crisis, advancements in imaging technology, and advancements in pain management.
In the coming years, the osteoarthritis market is predicted to witness substantial expansion. It’s projected to inflate to a staggering $10.74 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 9.4%. The surge in this period can be accounted to factors like non-pharmacological approaches, disease-modifying osteoarthritis drugs (dmoads), personalized medicine, along with telehealth and remote monitoring. The forecast period is also expected to see key trends such as regenerative therapies, wearable technology, AI in diagnosis, and digital wellness tools.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13022&type=smp
What Growth-Enabling Forces Are Impacting The Osteoarthritis Market?
The surge in obesity-generated health issues is predicted to fuel the expansion of the osteoarthritis market. Disorders tied to obesity unfold from an overabundance of body fat, a result of excessive caloric intake surpassing the amount burned through physical activities and workouts, a diet heavy in processed or fast foods, and high alcohol consumption. The burden on joints from obesity can instigate osteoarthritis by exerting stress on joints, stirring up inflammation, and disrupting hormonal balance, hence amplifying the load borne by the joints. For example, the World Obesity Atlas 2022 released by the World Obesity Federation, a non-profit organization based in the UK, forecasts that by the year 2030, obesity will affect 1 billion people globally, which includes 1 in 7 men and 1 in 5 women. Moreover, by 2035, nearly 4 billion people or 51% of the worldwide population will either be overweight or obese. As such, the growth of the osteoarthritis market is being propelled by the rise in obesity-related health complications.
What Are The Main Segment Classifications In The Osteoarthritis Market?
The osteoarthritismarket covered in this report is segmented –
1) By Treatment: Medication; Surgery; Therapy
2) By Diagnosis: Imaging; Joint Fluid Analysis
3) By Route Of Administration: Parenteral Route; Topical Route; Oral Route
4) By Disease Type: Knee Osteoarthritis; Spine Osteoarthritis; Foot And Ankle Osteoarthritis; Shoulder Osteoarthritis; Hand Osteoarthritis
5) By End-User: Hospitals; Medical Institutes
Subsegments:
1) By Medication: Pain Relievers; Corticosteroids; Hyaluronic Acid Injections; Disease-Modifying Osteoarthritis Drugs (DMOADs)
2) By Surgery: Joint Replacement Surgery; Arthroscopy; Osteotomy; Joint Fusion
3) By Therapy: Physical Therapy; Occupational Therapy; Weight Management Programs; Assistive Devices
How Are Market Trends Influencing Competition In The Osteoarthritis Market?
Prominent organizations within the osteoarthritis market are pursuing strategic partnerships as a method to expand their market influence and intensify technology incorporation. This type of partnership commonly represents a cooperative alliance amongst several entities who pool their competencies, assets, and endeavours to realize shared targets. An example of this occurred in July 2024 when LG Chem, a pharmaceutical corporation from South Korea, utilized a collaboration with Yifan Pharmaceutical Co., Ltd., a Chinese pharmaceutical research and manufacturing company, to penetrate the Chinese market. They launched the Synovian injection for osteoarthritis, a treatment that offers similar therapeutic effects to conventional multi-injection treatments but requires only a single administration. The high molecular weight (10 million Dalton) hyaluronic acid included in Synovian enhances viscoelasticity and joint functionality, while also contributing to significant knee pain reduction based on clinical phase 3 trial results. These breakthroughs place Synovian in a favourable position as a practical choice for patients looking for accessible alleviation from osteoarthritis symptoms.
Which Firms Are Driving Innovation Within The Osteoarthritis Market?
Major companies operating in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Reckitt Benckiser Group PLC, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics PLC, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report
What Are The Emerging Regional Trends Driving The Osteoarthritis Market?
North America was the largest region in the osteoarthritis market in 2024. The regions covered in osteoarthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=13022&type=smp
Browse Through More Reports Similar to the Global Osteoarthritis Market 2025, By The Business Research Company
Arthritis Monoclonal Antibodie Global Market Report 2025
Psoriatic Arthritis Treatments Global Market Report 2025
Companion Animal Arthritis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
